ShangRing versus Mogen clamp for early infant male circumcision in eastern sub-Saharan Africa: A multicentre, non-inferiority, adaptive, randomised controlled trial
Document Type
Article (peer-reviewed)
Publication Date
10-1-2022
Abstract
Background: Use of medical devices represents a unique opportunity to facilitate scale-up of early infant male circumcision (EIMC) across sub-Saharan Africa. The ShangRing, a circumcision device prequalified by WHO, is approved for use in adults and adolescents and requires topical anaesthesia only. We aimed to investigate the safety and efficacy of the ShangRing versus the Mogen clamp for EIMC in infants across eastern sub-Saharan Africa. Methods: In this multicentre, non-inferiority, open-label, randomised controlled trial, we enrolled healthy male infants (aged Findings: Between Sept 17, 2018, and Dec 20, 2019, a total of 1420 infants were assessed for eligibility, of whom 1378 (97·0%) were enrolled. 689 (50·0%) infants were randomly assigned to undergo EIMC by ShangRing and 689 (50·0%) by Mogen clamp. 43 (6·2%) adverse events were observed in the ShangRing group and 61 (8·9%) in the Mogen clamp group (p=0·078). The most common treatment-related AE was intraoperative pain (Neonatal Infant Pain Scale score ≥5), with 19 (2·8%) events in the ShangRing and 23 (3·3%) in the Mogel clamp group. Rates of moderate and severe AEs were similar between both groups (29 [4·2%] in the ShangRing group vs 30 [4·4%] in the Mogen clamp group; difference –0·1%; one-sided 95% CI upper limit of 1·7%; p=0·89). No treatment-related deaths were reported. Interpretation: Use of the ShangRing device for EIMC showed safety, achieved high caregiver satisfaction, and did not differ from the Mogen clamp in other key measures. The ShangRing could be used by health systems and international organisations to further scale up EIMC across sub-Saharan Africa.
Recommended Citation
Basourakos, Spyridon P., Quincy G. Nang, Karla V. Ballman, Omar Al Hussein Al Awamlh, Nahid Punjani, Kaylee Ho, Mark A. Barone, Quentin D. Awori, Daniel Ouma, Jairus Oketch, Alice E. Christensen, Augustino Hellar, Maende Makokha, Alphonce Isangu, Robert Salim, Jackson Lija, Ronald H. Gray, Stephen Kiboneka, Aggrey Anok, Godfrey Kigozi, Regina Nakabuye, Charles Ddamulira, Andrew Mulooki, Silas Odiya, Rose Nazziwa, Marc Goldstein, Philip S. Li, and Richard K. Lee. 2022. “ShangRing versus Mogen clamp for early infant male circumcision in eastern sub-Saharan Africa: A multicentre, non-inferiority, adaptive, randomised controlled trial,” The Lancet Global Health 10(10): e1514–e1522.
DOI
10.1016/S2214-109X(22)00326-6
Language
English
https://doi.org/10.1016/S2214-109X(22)00326-6